banner2

Getting started
4-Ethynyltoluene

4-Ethynyltoluene - Factory, Suppliers, Manufacturers from China

4-Ethynyltoluene, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Ethynyltoluene CAS 766-97-2 Purity 98.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Ethynyltoluene CAS 766-97-2 Purity >98.0% (GC)
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...

2022.12.12 23:21:12
2022.08.21 13:37:43
2022.07.28 12:16:32
2022.04.11 03:01:29
2022.03.12 19:13:07
2021.11.13 13:31:15

related search